CIGNA Co. (NYSE:CI) EVP John M. Murabito sold 28,037 shares of the stock in a transaction on Wednesday, January 10th. The stock was sold at an average price of $205.68, for a total value of $5,766,650.16. Following the completion of the transaction, the executive vice president now directly owns 60,290 shares in the company, valued at $12,400,447.20. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
CIGNA Co. (CI) traded down $8.05 during midday trading on Monday, hitting $196.41. The company’s stock had a trading volume of 2,223,581 shares, compared to its average volume of 1,469,275. The company has a market capitalization of $49,910.00, a PE ratio of 21.51, a P/E/G ratio of 1.30 and a beta of 0.44. CIGNA Co. has a 52 week low of $141.93 and a 52 week high of $227.13. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.37 and a quick ratio of 0.39.
CIGNA (NYSE:CI) last posted its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.94 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.87 by $0.07. The company had revenue of $10.53 billion for the quarter, compared to analysts’ expectations of $10.28 billion. CIGNA had a return on equity of 18.84% and a net margin of 5.38%. The firm’s revenue was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.87 earnings per share. sell-side analysts predict that CIGNA Co. will post 12.42 earnings per share for the current year.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Saratoga Research & Investment Management purchased a new position in CIGNA during the 3rd quarter worth approximately $112,000. Stuart Chaussee & Associates Inc. purchased a new position in shares of CIGNA during the 4th quarter valued at $122,000. Cerebellum GP LLC purchased a new position in shares of CIGNA during the 4th quarter valued at $127,000. Capstone Investment Advisors Netherlands B.V. purchased a new position in shares of CIGNA during the 2nd quarter valued at $106,000. Finally, Horan Capital Advisors LLC. purchased a new position in shares of CIGNA during the 3rd quarter valued at $123,000. Hedge funds and other institutional investors own 88.04% of the company’s stock.
CI has been the topic of several research reports. Zacks Investment Research upgraded CIGNA from a “hold” rating to a “buy” rating and set a $214.00 price target for the company in a research note on Monday, October 9th. Jefferies Group lifted their price target on CIGNA from $201.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. BMO Capital Markets started coverage on CIGNA in a research note on Monday, October 16th. They issued a “market perform” rating and a $210.00 price target for the company. Credit Suisse Group started coverage on CIGNA in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 target price for the company. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $220.00 target price (up from $185.00) on shares of CIGNA in a research note on Friday, November 3rd. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $210.12.
ILLEGAL ACTIVITY WARNING: “Insider Selling: CIGNA Co. (NYSE:CI) EVP Sells 28,037 Shares of Stock” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/02/05/john-m-murabito-sells-28037-shares-of-cigna-co-ci-stock.html.
CIGNA Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.